NCI Inc (NCIT) 8.35 $NCIT
Shares of NCIT Down 12.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - 53 mins ago
SmarTrend identified a Downtrend for NCI (NASDAQ:NCIT) on April 14th, 2014 at $9.54. In approximately 4 weeks, NCI has returned 12.10% as of today's recent price of $8.38.
CACI Q3 Earnings Way Ahead of Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 3:30PM CDT
CACI International Inc. (CACI) reported relatively modest third quarter fiscal 2014 results with a focused market-driven strategy and strong cash flow.
NCI Reports First Quarter 2014 Financial and Operating Results
Business Wire - Wed Apr 30, 3:02PM CDT
--Adjusted EPS of $0.16(1) exceeds high end of guidance by $0.02;
78.3% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Wed Apr 09, 9:08AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 5 months, NCI has returned 78.33% as of today's recent price of $10.37.
NCI Awarded $19 Million Task Order to Support U.S. Army Information Systems Engineering Command
Business Wire - Tue Apr 08, 7:05AM CDT
NCI, Inc. (NASDAQ: NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was awarded a task order valued at $19.4 million under the Total Engineering and Information Systems (TEIS) III contract for IT services in support of the U.S. Army Information Systems Engineering Command (USAISEC), Fort Detrick, Maryland, Engineering Directorate (ISEC-FDED).
NCI Schedules First Quarter 2014 Earnings Conference Call for April 30, 2014
Business Wire - Wed Apr 02, 7:03AM CDT
NCI, Inc. (NASDAQ:NCIT) announced today it will issue its first quarter 2014 financial results for the period ended March 31, 2014, after the market closes on Wednesday, April 30, 2014. Management will then discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern time.
Shares of NCIT Up 91.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 01, 4:38PM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 5 months, NCI has returned 91.57% as of today's recent price of $11.14.
NCI Up 99.6% Since SmarTrend Uptrend Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 18, 9:34AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 99.60% as of today's recent price of $11.61.
91.4% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 11, 9:09AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 91.40% as of today's recent price of $11.13.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Computer Sciences Corporation (CSC) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:40AM CST
Computer Sciences Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
Research and Markets: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Research Report
Business Wire - Fri Feb 28, 5:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/4s4f23/hidradenitis) has announced the addition of the "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" report to their offering.
Lubega Predicts Ko Win
by Moses Mugalu - All Africa Global Media - Wed Feb 26, 12:33AM CST
Professional boxer Joseph Lubega has predicted a knockout victory over South African Ryno Liebenberg in their scheduled World Boxing Council International (WBC-I) light heavyweight title contest due this Saturday, March 1 in Johannesburg.
Can NCI (NCIT) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
Stock of NCI looks promising, as it is seeing solid activity on the earnings estimate revision front
Ebix Inc. (EBIX) Jumps: Stock Rises 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:18AM CST
Ebix Inc. (EBIX) was a big mover last session, as the company saw its shares rise by over 9% on the day.
Nasdaq stocks posting largest volume increases
AP - Tue Feb 18, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Shares of NCIT Down 12.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - 53 mins ago
SmarTrend identified a Downtrend for NCI (NASDAQ:NCIT) on April 14th, 2014 at $9.54. In approximately 4 weeks, NCI has returned 12.10% as of today's recent price of $8.38.
CACI Q3 Earnings Way Ahead of Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 3:30PM CDT
CACI International Inc. (CACI) reported relatively modest third quarter fiscal 2014 results with a focused market-driven strategy and strong cash flow.
NCI Reports First Quarter 2014 Financial and Operating Results
Business Wire - Wed Apr 30, 3:02PM CDT
--Adjusted EPS of $0.16(1) exceeds high end of guidance by $0.02;
78.3% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Wed Apr 09, 9:08AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 5 months, NCI has returned 78.33% as of today's recent price of $10.37.
NCI Awarded $19 Million Task Order to Support U.S. Army Information Systems Engineering Command
Business Wire - Tue Apr 08, 7:05AM CDT
NCI, Inc. (NASDAQ: NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was awarded a task order valued at $19.4 million under the Total Engineering and Information Systems (TEIS) III contract for IT services in support of the U.S. Army Information Systems Engineering Command (USAISEC), Fort Detrick, Maryland, Engineering Directorate (ISEC-FDED).
NCI Schedules First Quarter 2014 Earnings Conference Call for April 30, 2014
Business Wire - Wed Apr 02, 7:03AM CDT
NCI, Inc. (NASDAQ:NCIT) announced today it will issue its first quarter 2014 financial results for the period ended March 31, 2014, after the market closes on Wednesday, April 30, 2014. Management will then discuss the results as well as operating trends and future performance expectations on a conference call beginning at 4:30 p.m. Eastern time.
Shares of NCIT Up 91.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 01, 4:38PM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 5 months, NCI has returned 91.57% as of today's recent price of $11.14.
NCI Up 99.6% Since SmarTrend Uptrend Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 18, 9:34AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 99.60% as of today's recent price of $11.61.
91.4% Return Seen to Date on SmarTrend NCI Call (NCIT)
Comtex SmarTrend(R) - Tue Mar 11, 9:09AM CDT
SmarTrend identified an Uptrend for NCI (NASDAQ:NCIT) on November 6th, 2013 at $5.82. In approximately 4 months, NCI has returned 91.40% as of today's recent price of $11.13.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Computer Sciences Corporation (CSC) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:40AM CST
Computer Sciences Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
Research and Markets: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014 Research Report
Business Wire - Fri Feb 28, 5:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/4s4f23/hidradenitis) has announced the addition of the "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2014" report to their offering.
Lubega Predicts Ko Win
by Moses Mugalu - All Africa Global Media - Wed Feb 26, 12:33AM CST
Professional boxer Joseph Lubega has predicted a knockout victory over South African Ryno Liebenberg in their scheduled World Boxing Council International (WBC-I) light heavyweight title contest due this Saturday, March 1 in Johannesburg.
Can NCI (NCIT) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:47AM CST
Stock of NCI looks promising, as it is seeing solid activity on the earnings estimate revision front
Ebix Inc. (EBIX) Jumps: Stock Rises 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 8:18AM CST
Ebix Inc. (EBIX) was a big mover last session, as the company saw its shares rise by over 9% on the day.
Nasdaq stocks posting largest volume increases
AP - Tue Feb 18, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
